151 related articles for article (PubMed ID: 24280874)
1. FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
Papadia C; Louwagie J; Del Rio P; Grooteclaes M; Coruzzi A; Montana C; Novelli M; Bordi C; de' Angelis GL; Bassett P; Bigley J; Warren B; Atkin W; Forbes A
Inflamm Bowel Dis; 2014 Feb; 20(2):271-7. PubMed ID: 24280874
[TBL] [Abstract][Full Text] [Related]
2. Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.
Melotte V; Yi JM; Lentjes MH; Smits KM; Van Neste L; Niessen HE; Wouters KA; Louwagie J; Schuebel KE; Herman JG; Baylin SB; van Criekinge W; Meijer GA; Ahuja N; van Engeland M
Cancer Prev Res (Phila); 2015 Feb; 8(2):157-64. PubMed ID: 25538088
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
4. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer.
Gerecke C; Scholtka B; Löwenstein Y; Fait I; Gottschalk U; Rogoll D; Melcher R; Kleuser B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2097-107. PubMed ID: 25902909
[TBL] [Abstract][Full Text] [Related]
7. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.
Azuara D; Aussó S; Rodriguez-Moranta F; Guardiola J; Sanjuan X; Lobaton T; Boadas J; Piqueras M; Monfort D; Guinó E; Moreno V; Capellá G; de Oca J
Inflamm Bowel Dis; 2018 Nov; 24(12):2555-2564. PubMed ID: 30099509
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
[TBL] [Abstract][Full Text] [Related]
9. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
[TBL] [Abstract][Full Text] [Related]
11. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
[TBL] [Abstract][Full Text] [Related]
12. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
15. Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-Grade Dysplasia in Patients With Inflammatory Bowel Disease.
Kisiel JB; Klepp P; Allawi HT; Taylor WR; Giakoumopoulos M; Sander T; Yab TC; Moum BA; Lidgard GP; Brackmann S; Mahoney DW; Roseth A; Ahlquist DA
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):914-921.e5. PubMed ID: 29775793
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.
Dhir M; Montgomery EA; Glöckner SC; Schuebel KE; Hooker CM; Herman JG; Baylin SB; Gearhart SL; Ahuja N
J Gastrointest Surg; 2008 Oct; 12(10):1745-53. PubMed ID: 18716850
[TBL] [Abstract][Full Text] [Related]
19. PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis.
Ludwig K; Fassan M; Mescoli C; Pizzi M; Balistreri M; Albertoni L; Pucciarelli S; Scarpa M; Sturniolo GC; Angriman I; Rugge M
Virchows Arch; 2013 Jan; 462(1):57-63. PubMed ID: 23224068
[TBL] [Abstract][Full Text] [Related]
20. Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
Kisiel JB; Yab TC; Nazer Hussain FT; Taylor WR; Garrity-Park MM; Sandborn WJ; Loftus EV; Wolff BG; Smyrk TC; Itzkowitz SH; Rubin DT; Zou H; Mahoney DW; Ahlquist DA
Aliment Pharmacol Ther; 2013 Mar; 37(5):546-54. PubMed ID: 23347191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
